Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

In Vitro and In Vivo Effectiveness of an Innovative Silver-Copper Nanoparticle Coating of Catheters To Prevent Methicillin-Resistant Staphylococcus aureus Infection.

Ballo MK, Rtimi S, Pulgarin C, Hopf N, Berthet A, Kiwi J, Moreillon P, Entenza JM, Bizzini A.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5349-56. doi: 10.1128/AAC.00959-16.

PMID:
27353266
2.

Peripheral Intravenous Catheter Placement Is an Underrecognized Source of Staphylococcus aureus Bloodstream Infection.

Austin ED, Sullivan SB, Whittier S, Lowy FD, Uhlemann AC.

Open Forum Infect Dis. 2016 Apr 6;3(2):ofw072. doi: 10.1093/ofid/ofw072.

3.

Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection.

Anderson AS, Scully IL, Buurman ET, Eiden J, Jansen KU.

MBio. 2016 Mar 8;7(2):e00225. doi: 10.1128/mBio.00225-16.

4.

Prevalence of qacA/B Genes and Mupirocin Resistance Among Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates in the Setting of Chlorhexidine Bathing Without Mupirocin.

Warren DK, Prager M, Munigala S, Wallace MA, Kennedy CR, Bommarito KM, Mazuski JE, Burnham CA.

Infect Control Hosp Epidemiol. 2016 May;37(5):590-7. doi: 10.1017/ice.2016.1.

PMID:
26828094
6.

Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States.

Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NT, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA.

MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31.

7.

Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.

Mendes RE, Deshpande LM, Costello AJ, Farrell DJ, Jones RN, Flamm RK.

Microb Drug Resist. 2016 Jan;22(1):53-8. doi: 10.1089/mdr.2014.0307.

8.
9.

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr.

Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14. Review.

10.

Insights into temporal patterns of hospital patient safety from routinely collected electronic data.

Gallego B, Magrabi F, Concha OP, Wang Y, Coiera E.

Health Inf Sci Syst. 2015 Feb 24;3(Suppl 1 HISA Big Data in Biomedicine and Healthcare 2013 Con):S2. doi: 10.1186/2047-2501-3-S1-S2.

11.

In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.

Lepak AJ, Marchillo K, Craig WA, Andes DR.

Antimicrob Agents Chemother. 2015 Feb;59(2):1258-64. doi: 10.1128/AAC.04444-14.

12.

Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals.

Lewis SS, Walker VJ, Lee MS, Chen L, Moehring RW, Cox CE, Sexton DJ, Anderson DJ.

Infect Control Hosp Epidemiol. 2014 Dec;35(12):1452-7. doi: 10.1086/678594.

13.

Chemical Composition, Modulatory Bacterial Resistance and Antimicrobial Activity of Essential Oil the Hyptis martiusii Benth by Direct and Gaseous Contact.

de Oliveira AD, Galvao Rodrigue FF, Douglas Melo Coutinho H, da Costa JG, de Menezes IR.

Jundishapur J Nat Pharm Prod. 2014 Jun 29;9(3):e13521.

14.

Infection prevention practices in neonatal intensive care units reporting to the national healthcare safety network.

Hocevar SN, Lessa FC, Gallagher L, Conover C, Gorwitz R, Iwamoto M.

Infect Control Hosp Epidemiol. 2014 Sep;35(9):1126-32. doi: 10.1086/677636.

15.

Management practices and major infections after cardiac surgery.

Gelijns AC, Moskowitz AJ, Acker MA, Argenziano M, Geller NL, Puskas JD, Perrault LP, Smith PK, Kron IL, Michler RE, Miller MA, Gardner TJ, Ascheim DD, Ailawadi G, Lackner P, Goldsmith LA, Robichaud S, Miller RA, Rose EA, Ferguson TB Jr, Horvath KA, Moquete EG, Parides MK, Bagiella E, O'Gara PT, Blackstone EH; Cardiothoracic Surgical Trials Network (CTSN)..

J Am Coll Cardiol. 2014 Jul 29;64(4):372-81. doi: 10.1016/j.jacc.2014.04.052.

16.

Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.

Jamal MA, Rosenblatt J, Jiang Y, Hachem R, Chaftari AM, Raad II.

Antimicrob Agents Chemother. 2014 Sep;58(9):5291-6. doi: 10.1128/AAC.02886-14.

17.

Emerging technologies for rapid identification of bloodstream pathogens.

Kothari A, Morgan M, Haake DA.

Clin Infect Dis. 2014 Jul 15;59(2):272-8. doi: 10.1093/cid/ciu292. Review.

18.

Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity.

O'Daniel PI, Peng Z, Pi H, Testero SA, Ding D, Spink E, Leemans E, Boudreau MA, Yamaguchi T, Schroeder VA, Wolter WR, Llarrull LI, Song W, Lastochkin E, Kumarasiri M, Antunes NT, Espahbodi M, Lichtenwalter K, Suckow MA, Vakulenko S, Mobashery S, Chang M.

J Am Chem Soc. 2014 Mar 5;136(9):3664-72. doi: 10.1021/ja500053x.

19.

Methicillin-resistant Staphylococcus aureus colonization among health care workers in a downtown emergency department in Toronto, Ontario.

Saito G, Thom J, Wei Y, Gnanasuntharam P, Gnanasuntharam P, Kreiswirth N, Willey B, Loftus M, Varner C, Porter V, McGeer A, Borgundvaag B.

Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e57-60.

20.

Six components necessary for effective public health program implementation.

Frieden TR.

Am J Public Health. 2014 Jan;104(1):17-22. doi: 10.2105/AJPH.2013.301608.

Items per page

Supplemental Content

Support Center